SOUTH SAN FRANCISCO, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer and President of Sunesis, will present at two upcoming investor conferences;
- Leerink Global Healthcare Conference
Thursday, February 13th at 11:10 AM Eastern Time
The Waldorf Astoria, New York City
- 2014 RBC Capital Markets' Global Healthcare Conference
Tuesday, February 25th at 1:35 PM Eastern Time
The New York Palace Hotel, New York City
A live webcast of the presentations will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit http://www.sunesis.com.
CONTACT: Investor and Media Inquiries: David Pitts Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717 Eliza Schleifstein Argot Partners 917-763-8106 email@example.com
Source:Sunesis Pharmaceuticals, Inc.